Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FAM219B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SEMA5A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCAF11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TGFA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LAMA5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM50B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YARS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM149A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CALU - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDIA4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCID2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EID1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ST6GALNAC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC1A4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC12A8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DLG3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANGEL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRKD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PYCR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIAA1217 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on